Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events
Authors:
Open Access
- 11 April 2024
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 90 (7) , 1688-1698
Abstract
Aims: While diagnostic codes from administrative health data might be a valuable source to identify adverse drug events (ADEs), their ability to identify unintended harms remains unclear. We validated claims‐based diagnosis codes for ADEs based on events identified in a prospective cohort study and assessed whether key attributes predicted their documentation in administrative data.Methods: This was a retrospective analysis of 3 prospective cohorts in British Columbia, from 2008 to 2015 (n = 13 969). We linked prospectively identified ADEs to administrative insurance data to examine the sensitivity and specificity of different diagnostic code schemes. We used logistic regression to assess which key attributes (e.g., type of event, symptoms and culprit medications) were associated with better documentation of ADEs in administrative data.Results: Among 1178 diagnosed events, the sensitivity of the diagnostic codes in administrative data ranged from 3.4 to 52.6%, depending on the database and codes used. We found that documentation was worse for certain types of ADEs (dose‐related: odds ratio [OR]: 0.32, 95% confidence interval [CI]: 0.15, 0.69; nonadherence events (OR: 0.35, 95% CI: 0.20, 0.62), and better for those experiencing arrhythmias (OR: 4.19, 95% CI: 0.96, 18.28).Conclusion: ADEs were not well documented in administrative data. Alternative methods should be explored to capture ADEs for health research.Keywords
Funding Information
- Canadian Institutes of Health Research (201610MDR)
This publication has 14 references indexed in Scilit:
- Use of ICD‐10‐CM T codes in hospital claims data to identify adverse drug events in TaiwanJournal of Clinical Pharmacy and Therapeutics, 2020
- Prospective Validation of Clinical Criteria to Identify Emergency Department Patients at High Risk for Adverse Drug EventsAcademic Emergency Medicine, 2018
- Adverse drug events in German hospital routine data: A validation of International Classification of Diseases, 10th revision (ICD-10) diagnostic codesPLOS ONE, 2017
- Impact of early in-hospital medication review by clinical pharmacists on health services utilizationPLOS ONE, 2017
- The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and StrategiesAmerican Society of Clinical Oncology Educational Book, 2016
- A Comparison of Cost Effectiveness Using Data from Randomized Trials or Actual Clinical Practice: Selective Cox-2 Inhibitors as an ExamplePLOS Medicine, 2009
- Cost-effectiveness of warfarin: Trial versus “real-world” stroke prevention in atrial fibrillationAmerican Heart Journal, 2009
- Primer: administrative health databases in observational studies of drug effects—advantages and disadvantagesNature Clinical Practice Rheumatology, 2007
- Applied Logistic Regression2000
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981